Literature DB >> 11407350

Hematopoietic stem-cell transplants using umbilical-cord blood.

E Gluckman.   

Abstract

Mesh：

Year:  2001        PMID： 11407350     DOI： 10.1056/NEJM200106143442410

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Delta-1 enhances marrow and thymus repopulating ability of human CD34(+)CD38(-) cord blood cells.

Authors:  Kohshi Ohishi; Barbara Varnum-Finney; Irwin D Bernstein
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Cryopreservation of hematopoietic stem cells.

Authors:  David Berz; Elise M McCormack; Eric S Winer; Gerald A Colvin; Peter J Quesenberry
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

3.  Posttransplantation engraftment and safety of cord blood transplantation with grafts containing relatively low cell doses in adults.

Authors:  Satoshi Takahashi; Jun Ooi; Akira Tomonari; Takaaki Konuma; Nobuhiro Tsukada; Arinobu Tojo; Takuhiro Yamaguchi; Shigetaka Asano
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

4.  Isolation and therapeutic potential of human haemopoietic stem cells.

Authors:  Andrew D Clark; Heather G Jørgensen; Joanne Mountford; Tessa L Holyoake
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

5.  Stem cells: From embryology to cellular therapy? An appraisal of the present state of art.

Authors:  Sandro Eridani; Vittorio Sgaramella; Lidia Cova
Journal:  Cytotechnology       Date:  2004-03       Impact factor: 2.058

6.  Pre-birth selection of umbilical cord blood donors.

Authors:  Patrizia Urciuoli; Simona Passeri; Francesca Ceccarelli; Barbara Luchetti; Aldo Paolicchi; Simone Lapi; Francesca Nocchi; Roberta Lamanna; Mariacarla Iorio; Renato Vanacore; Alessandro Mazzoni; Fabrizio Scatena
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

7.  Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation.

Authors:  C Basford; N Forraz; S Habibollah; K Hanger; C P McGuckin
Journal:  Cell Prolif       Date:  2009-09-15       Impact factor: 6.831

8.  Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

Authors:  Marcos de Lima; Ian McNiece; Simon N Robinson; Mark Munsell; Mary Eapen; Mary Horowitz; Amin Alousi; Rima Saliba; John D McMannis; Indreshpal Kaur; Partow Kebriaei; Simrit Parmar; Uday Popat; Chitra Hosing; Richard Champlin; Catherine Bollard; Jeffrey J Molldrem; Roy B Jones; Yago Nieto; Borje S Andersson; Nina Shah; Betul Oran; Laurence J N Cooper; Laura Worth; Muzaffar H Qazilbash; Martin Korbling; Gabriela Rondon; Stefan Ciurea; Doyle Bosque; Ila Maewal; Paul J Simmons; Elizabeth J Shpall
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

9.  Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant.

Authors:  William Hwang Ying Khee; Patrick Tan Huat Chye; Tan Cheng Hoe; How Gee Fung; Heng Khee Khiang; Goh Yeow Tee
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 10.  Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases.

Authors:  Franco Aversa; Massimo F Martelli
Journal:  Springer Semin Immunopathol       Date:  2004-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.